Association of metformin, dipeptidyl dipeptidase-4 inhibitors, and insulin with COVID-19-related hospital outcomes in patients with type 2 diabetes
Obiri-Yeboah et al., Endocrine Practice, doi:10.1016/j.eprac.2023.06.001
https://c19early.org/obiriyeboah.html